Effect of Empiric Anti–Mycobacterium tuberculosis Therapy on Survival Among Human Immunodeficiency Virus–Infected Adults Admitted With Sepsis to a Regional Referral Hospital in Uganda

Thumbnail Image
Files
Effect of Empiric Anti–Mycobacterium tuberculosis Therapy on Survival Among Human Immunodeficiency Virus–Infected Adults Admitted With Sepsis to a Regional Referral Hospital in Uganda.pdf (239.17 KB)
Date
2019
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
In Open Forum Infectious Diseases.
Abstract
Mycobacterium tuberculosis is the leading cause of bloodstream infection among human immunodeficiency virus (HIV)–infected patients with sepsis in sub-Saharan Africa and is associated with high mortality rates. We conducted a retrospective study of HIV-infected adults with sepsis at the Mbarara Regional Referral Hospital in Uganda to measure the proportion who received antituberculosis therapy and to determine the relationship between antituberculosis therapy and 28-day survival.
Description
Keywords
Mycobacterium tuberculosis, sepsis
Citation
Hazard, R. H., Kagina, P., Kitayimbwa, R., Male, K., McShane, M., Mubiru, D., ... & Abdallah, A. (2019). Effect of empiric anti-Mycobacterium tuberculosis therapy on survival among HIV-infected adults admitted with sepsis to a regional referral hospital in Uganda. In Open Forum Infectious Diseases.https://doi.org/10.1093/ofid/ofz140
URI
https://nru.uncst.go.ug/handle/123456789/7818
Collections
Medical and Health Sciences